日立736 - 30型化学分析仪的临床评估

Clinical assessment of the Hitachi 736-30 chemistry analyzer.

作者信息

Schotters S B, McBride J H, Rodgerson D O, McGinley M H, Pisa M

机构信息

UCLA School of Medicine, Department of Pathology and Laboratory Medicine, 90024-1713.

出版信息

J Clin Lab Anal. 1990;4(2):157-60. doi: 10.1002/jcla.1860040215.

DOI:10.1002/jcla.1860040215

PMID:2107291

Abstract

We assessed the Hitachi 736-30 as a possible replacement for the SMAC I and as a laboratory cost-saving measure. For 24 analytes, both intra- and interassay precisions were acceptable; they also had good measuring ranges. Essentially no interference from lipemia was observed, while minimal interference from bilirubin was demonstrated. Hemoglobin interfered in the measurement of 12 of the analytes. Correlation with the SMAC I, Demand, Astra-8, ACA, and Varian Atomic Absorption Spectrophotometer was found to be acceptable, except for chloride which showed poor correlation with SMAC I and Astra-8 (Hitachi = 0.888 [SMAC] + 11.102, r = 0.9652; Hitachi = 0.885 [Astra] + 10.264, r = 0.9136). The Hitachi 736-30 offers reagent and method flexibility, high volume capability, and "walk-away" operation.

摘要

我们评估了日立736 - 30型仪器，看其能否替代SMAC I型仪器以及是否能作为实验室节省成本的措施。对于24种分析物，批内和批间精密度均可接受；它们也有良好的测量范围。基本未观察到脂血的干扰，而胆红素的干扰极小。血红蛋白干扰了12种分析物的测量。与SMAC I型、德门德、阿斯特拉 - 8、ACA和瓦里安原子吸收分光光度计的相关性被认为是可接受的，但氯化物与SMAC I型和阿斯特拉 - 8的相关性较差（日立=0.888[SMAC]+11.102，r = 0.9652；日立=0.885[阿斯特拉]+10.264，r = 0.9136）。日立736 - 30型仪器具有试剂和方法的灵活性、高检测量能力以及“无需值守”的操作特点。